Abstract
In this population of COVID-19 patients with high prevalence of underlying immune defect, a high risk of infections was noted. Mechanical ventilation (MV) and use of steroids were independently associated with infection rate.
Introduction
Early in the COVID-19 pandemic, clinicians frequently prescribed empirical antibiotics due to concerns regarding co-infections. However, data on the actual frequency and risk factors for these infections remained sparse, particularly for "high-risk" patients—those with underlying malignancies or organ transplants. In severe COVID-19 patients, especially those with pre-existing immune defects, secondary infections represent a major complication, often affecting over a quarter of patients within the first 10 days of ICU admission. While steroids like dexamethasone have become standard for treating COVID-19-related inflammation, emerging evidence suggests they may significantly increase the risk of hospital-acquired infections (HAIs) in vulnerable populations without a clear mortality benefit.
Methods
This retrospective single-center study analyzed 100 consecutive adult patients admitted to the ICU at Saint-Louis University Hospital in Paris between March and May 2020. A defining characteristic of this cohort was its unique composition: 34% of patients had underlying malignancies or were solid organ transplant recipients, a much higher prevalence of immune defects than the typical 4% seen in other COVID-19 studies.
To address the complexities of ICU data, the researchers employed several robust statistical techniques, including competing-risk analysis to avoid overestimating infection risk and propensity score matching to create comparable groups for evaluating the impact of dexamethasone.
Results
The study revealed a stark contrast between community-acquired and hospital-acquired infections. Only 7% of patients presented with a bacterial infection upon admission. However, the incidence density of HAIs in the ICU was 125 events per 1,000 ICU-days. By day 10, 27% of the total population had developed an infection.
Risk Factors for Infection
Mechanical ventilation (MV) emerged as the primary gateway for secondary hits, with a sub-hazard ratio of 11.0. For patients on MV, the infection risk jumped to 48% at day 10, compared to just 2.2% for non-ventilated patients. The physical breach of the airway combined with the patient's weakened state makes intubation a massive risk factor for pneumonia, predominantly caused by Gram-negative bacilli such as Pseudomonas aeruginosa and Klebsiella species.
The Impact of Steroids
Dexamethasone use was independently associated with a nearly threefold increase in infections (35% vs. 13% in matched controls; $p=0.01$). Crucially, in this specific cohort, the use of steroids did not show a significant influence on mortality, highlighting a potential "double-edged sword" effect in immunocompromised patients.
Discussion and Conclusion
While secondary infections are frequent, overall ICU mortality (28%) was independently associated with patient severity (SAPS II score) and underlying malignancy rather than the infections themselves.
The study is limited by its single-center, retrospective design and a relatively small sample size of 100 patients. Despite propensity matching, confounding by disease severity remains a challenge. These findings suggest a need for refined antibiotic stewardship to avoid unnecessary usage at admission and call for larger studies to explore the influence of steroid dosing on infection rates in immunocompromised COVID-19 populations.
Summary updated